Study Title and Description
Randomized trial of everolimus-facilitated calcineurin inhibitor minimization over 24 months in renal transplantation.
Key Questions Addressed
|3||In adult renal transplants, how do immunosuppressive regimens designed to reduce or eliminate exposure to CNI toxicity compare with each other and with full-dose CNI regimens for health outcomes? AND How does the type of induction agent (including when no induction is used) and the use of concurrent immunosuppressive agents affect outcomes of regimens that reduce or eliminate CNI exposure?|
Primary Publication Information
|Title||Randomized trial of everolimus-facilitated calcineurin inhibitor minimization over 24 months in renal transplantation.|
|Author||Cibrik D., Silva HT., Vathsala A., Lackova E., Cornu-Artis C., Walker RG., Wang Z., Zibari GB., Shihab F., Kim YS.|
|Country||Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. firstname.lastname@example.org|
Pubmed ID: 23422495
Secondary Publication Information
There are currently no secondary publications defined for this study.
Extraction Form: Comparative Effectiveness of Regimens
Results & Comparisons
No Results found.